Skip to content

Opus Model 4001 Implantable Pacemaker Pulse-Generator

by Ela Medical, Inc.

510(k) K894065

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK894065 Date26 Sep 1989ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Opus Model 4001
510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Opus Model 4001 is an implantable pacemaker pulse-generator, classified as a Class III medical device under FDA regulations. It is designed to regulate heart rhythm by delivering electrical impulses to the heart muscle when the natural pacemaker fails to do so, ensuring proper cardiac function in patients with bradycardia or other conduction disorders.

This device is intended for surgical implantation by qualified healthcare professionals in a sterile operating environment. Supplied as a single-use, non-reusable component, it must be handled under aseptic conditions and stored according to manufacturer guidelines. The Opus Model 4001 complies with FDA 510(k) clearance (K894065) and is regulated under the Implantable Pacemaker Pulse-Generator category (DXY), adhering to strict medical device standards for cardiovascular applications.

Other devices from Ela Medical, Inc.

See all devices from Ela Medical, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Opus Model 4001 used for in clinical practice?

    The Opus Model 4001 is an implantable pacemaker pulse-generator designed to regulate heart rhythm by delivering electrical impulses to the heart muscle when the natural pacemaker fails. It is specifically intended for patients with bradycardia or conduction disorders, ensuring proper cardiac function by compensating for slow or irregular heartbeats.

  • Is the Opus Model 4001 meant to be reused, or is it single-use only?

    The Opus Model 4001 is supplied as a single-use, non-reusable component. Due to its sterile implantation requirements, it must be handled under aseptic conditions and discarded after one use to maintain patient safety and device efficacy.

  • How should the Opus Model 4001 be stored before implantation?

    The device must be stored according to the manufacturer’s guidelines, which likely include maintaining sterility and proper environmental conditions (e.g., temperature, humidity) to preserve its integrity until surgical implantation. Since it is non-reusable, storage should follow aseptic protocols to prevent contamination.

  • What regulatory pathway was followed for FDA clearance of the Opus Model 4001?

    The Opus Model 4001 received FDA clearance through a 510(k) submission, classified as a Class III medical device under the Implantable Pacemaker Pulse-Generator category (product code DXY). The clearance was granted by the FDA’s Cardiovascular (CV) Advisory Committee under a Traditional 510(k) review, with a decision date of September 26, 1989, and a clearance number of K894065.

  • Who is the manufacturer responsible for the Opus Model 4001, and where are they located?

    The manufacturer of the Opus Model 4001 is Ela Medical, Inc., headquartered at 15245 Minnetonka Blvd., Minnetonka, MN 55345, USA. For inquiries, contact information is available through the listed address or via the provided contact, Paul Kohl.